Decentralized Trials

Decentralized Trials

Products

Information

Clinical Ink is the leader in decentralized trial conduct. From our experience with an Ebola virus study of 5,000 patients in five countries in northwest Africa to our track record of successful bring your own device (BYOD) studies involving 15,000 patients across Phase I-IV+ clinical trials, we have the experience to virtualize whatever trial you present us. Your goal may be to decrease patient visits by one, or to eliminate them completely. Through our long-time, pioneering focus on direct data capture and fully integrated patient engagement, we have built a vast toolkit of solutions, technologies, and supportive industry best practices to make your decentralized trial a reality. Seamless integration with partner technologies, such as wearables or televisits, provides an efficient, holistic solution.
Clinical InkClinical Ink, a global clinical technology company, offers data certainty from source to submission. Our eSource clinical technology and configurable ePRO and eCOA modules — a suite of solutions for capturing and integrating electronic data from sites, clinicians, and patients at its source — naturally enhance your clinical trial workflow by reducing manual labor, providing anytime, anywhere data access, and saving resources as your trials progress. Accelerate the completion of key clinical development milestones in your study and confidently manage your trial’s critical decisions with our flexible menu of collaborative services, remote monitoring support, and a complete, real-time view of your trial. To learn more, visit www.clinicalink.com 

Join the event!